Search research articles
Contact Us
Filters
Showing results (21-30 of 159) with videos related to
Page
of 16
Sort By:
Journal of Medicinal Chemistry
|
April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
Tonia Kirschner, Matthias P Müller, Daniel Rauh
Bioorganic & Medicinal Chemistry
|
March 23, 2011
Using small molecules to target protein phosphatases
Viktor V Vintonyak, Herbert Waldmann, Daniel Rauh
Organic & Biomolecular Chemistry
|
October 4, 2007
Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct
Raynard Bateman, Daniel Rauh, Kevan M Shokat
ACS Chemical Biology
|
December 13, 2019
Augmented Reality in Scientific Publications - Taking the Visualization of 3D Structures to the Next Level
Patrik Wolle, Matthias P Müller, Daniel Rauh
Journal of Medicinal Chemistry
|
August 16, 2019
Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases
Janina Niggenaber, Julia Hardick, Jonas Lategahn, et al.
Journal of Molecular Biology
|
August 6, 2013
Structural characterization of the RLCK family member BSK8: a pseudokinase with an unprecedented architecture
Christian Grütter, Shivakumar Sreeramulu, Guido Sessa, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Spotlight on AKT: Current Therapeutic Challenges
Ina Landel, Lena Quambusch, Laura Depta, et al.
Cell Chemical Biology
|
August 6, 2019
Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules
Roger S Goody, Matthias P Müller, Daniel Rauh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer
Johannes M Heuckmann, Daniel Rauh, Roman K Thomas
Journal of Molecular Biology
|
July 10, 2003
ZZ made EZ: influence of inhibitor configuration on enzyme selectivity
Daniel Rauh, Gerhard Klebe, Jörg Stürzebecher, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 159) with videos related to
Sort By:
Page
of 16
Journal of Medicinal Chemistry
|
April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
Tonia Kirschner, Matthias P Müller, Daniel Rauh
Bioorganic & Medicinal Chemistry
|
March 23, 2011
Using small molecules to target protein phosphatases
Viktor V Vintonyak, Herbert Waldmann, Daniel Rauh
Organic & Biomolecular Chemistry
|
October 4, 2007
Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct
Raynard Bateman, Daniel Rauh, Kevan M Shokat
ACS Chemical Biology
|
December 13, 2019
Augmented Reality in Scientific Publications - Taking the Visualization of 3D Structures to the Next Level
Patrik Wolle, Matthias P Müller, Daniel Rauh
Journal of Medicinal Chemistry
|
August 16, 2019
Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases
Janina Niggenaber, Julia Hardick, Jonas Lategahn, et al.
Journal of Molecular Biology
|
August 6, 2013
Structural characterization of the RLCK family member BSK8: a pseudokinase with an unprecedented architecture
Christian Grütter, Shivakumar Sreeramulu, Guido Sessa, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Spotlight on AKT: Current Therapeutic Challenges
Ina Landel, Lena Quambusch, Laura Depta, et al.
Cell Chemical Biology
|
August 6, 2019
Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules
Roger S Goody, Matthias P Müller, Daniel Rauh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer
Johannes M Heuckmann, Daniel Rauh, Roman K Thomas
Journal of Molecular Biology
|
July 10, 2003
ZZ made EZ: influence of inhibitor configuration on enzyme selectivity
Daniel Rauh, Gerhard Klebe, Jörg Stürzebecher, et al.
Page
of 16